Volume 15 Issue 4
Jul.  2024
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2024  >  15(4): 548-557
China International Exchange and Promotive Association for Medical and Health Care (CPAM), Society of Liver Transplantation，Society of Kidney Transplantation; China Medicinal Biotech Association（CMBA）, Society of Biological Diagnostics, et al. Expert Consensus on quantify monitoring and assessment of immune cell function status and clinical application[J]. ORGAN TRANSPLANTATION, 2024, 15(4): 548-557. doi: 10.3969/j.issn.1674-7445.2024078
Citation: China International Exchange and Promotive Association for Medical and Health Care (CPAM), Society of Liver Transplantation，Society of Kidney Transplantation; China Medicinal Biotech Association（CMBA）, Society of Biological Diagnostics, et al. Expert Consensus on quantify monitoring and assessment of immune cell function status and clinical application[J]. ORGAN TRANSPLANTATION, 2024, 15(4): 548-557. doi: 10.3969/j.issn.1674-7445.2024078
shu

Expert Consensus on quantify monitoring and assessment of immune cell function status and clinical application

doi: 10.3969/j.issn.1674-7445.2024078
More Information
  • Corresponding author: He Qiang, Beijing Chaoyang Hospital of Capital Medical University, Beijing 100020, China, Email: heqiang349@sina.com; Li Xianliang, Beijing Chaoyang Hospital of Capital Medical University, Beijing 100020, China, Email: lixianliangbjcy@126.com
  • Received Date: 2024-02-27
    Available Online: 2024-06-26
  • Publish Date: 2024-07-15
    Abstract
  • The immune system is the important guarantee for maintaining the health of organ function and preventing diseases. The goal of immune health management and immune treatment is to restore the normal function of the immune system. The technical problems of how to inhibit or enhance the immune status has been solved in the field of immunology, but how to comprehensively detect and quantitatively evaluate the immune status is still a challenge. There is no mature solution at present. The quantification detection and visualization evaluation of immune status are of great significance for disease prevention and control, sub-health status management, and immune treatment. This expert consensus has carried out preliminary discussions on the definition of normal immune status and the comprehensive quantitative evaluation and visual scoring techniques of immune cell function status (immune function), put forward the basic concepts and thinking related to normal immune status, discussed the direction and principles of quantitative detection and evaluation of immune cell function status, and taken this as an opportunity to promote the decoding of immunity and the study of basic and clinical trials in the field of immune health.

     

    • FullText(HTML)
  • loading
    • References(53)
  • [1]
    DUNKELBERGER JR, SONG WC. Complement and its role in innate and adaptive immune responses[J]. Cell Res, 2010, 20(1): 34-50. DOI: 10.1038/cr.2009.139.
    [2]
    NETEA MG, DOMÍNGUEZ-ANDRÉS J, BARREIRO LB, et al. Defining trained immunity and its role in health and disease[J]. Nat Rev Immunol, 2020, 20(6): 375-388. DOI: 10.1038/s41577-020-0285-6.
    [3]
    NETEA MG, SCHLITZER A, PLACEK K, et al. Innate and adaptive immune memory: an evolutionary continuum in the host’s response to pathogens[J]. Cell Host Microbe, 2019, 25(1): 13-26. DOI: 10.1016/j.chom.2018.12.006.
    [4]
    BARRY KC, HSU J, BROZ ML, et al. A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments[J]. Nat Med, 2018, 24(8): 1178-1191. DOI: 10.1038/s41591-018-0085-8.
    [5]
    PERNOT S, TERME M, RADOSEVIC-ROBIN N, et al. Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance[J]. Gastric Cancer, 2020, 23(1): 73-81. DOI: 10.1007/s10120-019-00983-3.
    [6]
    HOSSEINI A, HASHEMI V, SHOMALI N, et al. Innate and adaptive immune responses against coronavirus[J]. Biomed Pharmacother, 2020, 132: 110859. DOI: 10.1016/j.biopha.2020.110859.
    [7]
    PALMER S, CUNNIFFE N, DONNELLY R. COVID-19 hospitalization rates rise exponentially with age, inversely proportional to thymic T-cell production[J]. J R Soc Interface, 2021, 18(176): 20200982. DOI: 10.1098/rsif.2020.0982.
    [8]
    李先亮, 贾亚男, 王若麟, 等. 创新免疫状态评估体系的建立及其在疾病诊疗中的应用[J]. 中国现代医学杂志, 2021, 31(16): 1-6. DOI: 10.3969/j.issn.1005-8982.2021.16.001.

    LI XL, JIA YN, WANG RL, et al. Research progress in novel approaches to immune status evaluation and their application in clinical practice[J]. China J Mod Med, 2021, 31(16): 1-6. DOI: 10.3969/j.issn.1005-8982.2021.16.001.
    [9]
    KOWALSKI RJ, POST DR, MANNON RB, et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay[J]. Transplantation, 2006, 82(5): 663-668. DOI: 10.1097/01.tp.0000234837.02126.70.
    [10]
    PALMER S, ALBERGANTE L, BLACKBURN CC, et al. Thymic involution and rising disease incidence with age[J]. Proc Natl Acad Sci U S A, 2018, 115(8): 1883-1888. DOI: 10.1073/pnas.1714478115.
    [11]
    LE SAUX S, WEYAND CM, GORONZY JJ. Mechanisms of immunosenescence: lessons from models of accelerated immune aging[J]. Ann N Y Acad Sci, 2012, 1247: 69-82. DOI: 10.1111/j.1749-6632.2011.06297.x.
    [12]
    SANMAMED MF, CHEN L. A paradigm shift in cancer immunotherapy: from enhancement to normalization[J]. Cell, 2019, 176(3): 677. DOI: 10.1016/j.cell.2019.01.008.
    [13]
    FENG F, ZHENG G, WANG Q, et al. Low lymphocyte count and high monocyte count predicts poor prognosis of gastric cancer[J]. BMC Gastroenterol, 2018, 18(1): 148. DOI: 10.1186/s12876-018-0877-9.
    [14]
    李瀚, 吕少诚, 贾亚男, 等. 中性粒细胞/淋巴细胞比值与可切除远端胆管癌远期预后的相关性研究[J]. 解放军医学院学报, 2020, 41(10): 959-962,982. DOI: 10.3969/j.issn.2095-5227.2020.10.002.

    LI H, LYU SC, JIA YN, et al. Correlation between neutrophil-to-lymphocyte ratio and long-term prognosis in resectable distal cholangiocarcinoma[J]. Acad J Chin PLA Med Sch, 2020, 41(10): 959-962,982. DOI: 10.3969/j.issn.2095-5227.2020.10.002.
    [15]
    FERNÁNDEZ-RUIZ M, KUMAR D, HUMAR A. Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation[J]. Clin Transl Immunology, 2014, 3(2): e12. DOI: 10.1038/cti.2014.3.
    [16]
    MECKIFF BJ, RAMÍREZ-SUÁSTEGUI C, FAJARDO V, et al. Imbalance of regulatory and cytotoxic SARS-CoV-2-reactive CD4+ T cells in COVID-19[J]. Cell, 2020, 183(5): 1340-1353. e16. DOI: 10.1016/j.cell.2020.10.001.
    [17]
    PENG X, OUYANG J, ISNARD S, et al. Sharing CD4+ T cell loss: when COVID-19 and HIV collide on immune system[J]. Front Immunol, 2020, 11: 596631. DOI: 10.3389/fimmu.2020.596631.
    [18]
    RODRIGO E, LÓPEZ-HOYOS M, CORRAL M, et al. ImmuKnow as a diagnostic tool for predicting infection and acute rejection in adult liver transplant recipients: a systematic review and meta-analysis[J]. Liver Transpl, 2012, 18(10): 1245-1253. DOI: 10.1002/lt.23497.
    [19]
    BERGLUND D, BENGTSSON M, BIGLARNIA A, et al. Screening of mortality in transplant patients using an assay for immune function[J]. Transpl Immunol, 2011, 24(4): 246-250. DOI: 10.1016/j.trim.2010.12.005.
    [20]
    XUE F, ZHANG J, HAN L, et al. Immune cell functional assay in monitoring of adult liver transplantation recipients with infection[J]. Transplantation, 2010, 89(5): 620-626. DOI: 10.1097/TP.0b013e3181c690fa.
    [21]
    黄小慧, 张英才, 朱曙光, 等. Cylex ImmuKnow免疫细胞功能检测在肝移植术后监测中的应用 [J/OL]. 中华肝脏外科手术学电子杂志, 2016, 5(5): 311-314. DOI: 10.3877/cma.j.issn.2095-3232.2016.05.010.

    HUANG XH, ZHANG YC, ZHU SG, et al. Application of Cylex Immu Know immune cell function assay in postoperative monitoring after liver transplantation[J/OL]. Chin J Hepatic Surg Electron Ed, 2016, 5(5): 311-314. DOI: 10.3877/cma.j.issn.2095-3232.2016.05.010.
    [22]
    QUAGLIA M, CENA T, FENOGLIO R, et al. Immune function assay (immunknow) drop over first 6months after renal transplant: a predictor of opportunistic viral infections?[J]. Transplant Proc, 2014, 46(7): 2220-2223. DOI: 10.1016/j.transproceed.2014.07.050.
    [23]
    LING X, XIONG J, LIANG W, et al. Can immune cell function assay identify patients at risk of infection or rejection? a meta-analysis[J]. Transplantation, 2012, 93(7): 737-743. DOI: 10.1097/TP.0b013e3182466248.
    [24]
    PICARDA E, BÉZIE S, VENTURI V, et al. MHC-derived allopeptide activates TCR-biased CD8+ Tregs and suppresses organ rejection[J]. J Clin Invest, 2014, 124(6): 2497-2512. DOI: 10.1172/JCI71533.
    [25]
    ZHENG C, ZHENG L, YOO JK, et al. Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing[J]. Cell, 2017, 169(7): 1342-1356. e16. DOI: 10.1016/j.cell.2017.05.035.
    [26]
    ZHUO Y, YANG X, SHUAI P, et al. Evaluation and comparison of adaptive immunity through analyzing the diversities and clonalities of T-cell receptor repertoires in the peripheral blood[J]. Front Immunol, 2022, 13: 916430. DOI: 10.3389/fimmu.2022.916430.
    [27]
    ZHANG L, YU X, ZHENG L, et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer[J]. Nature, 2018, 564(7735): 268-272. DOI: 10.1038/s41586-018-0694-x.
    [28]
    ZHANG Y, CHEN H, MO H, et al. Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer[J]. Cancer Cell, 2021, 39(12): 1578-1593. e8. DOI: 10.1016/j.ccell.2021.09.010.
    [29]
    ZHENG L, QIN S, SI W, et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells[J]. Science, 2021, 374(6574): abe6474. DOI: 10.1126/science.abe6474.
    [30]
    ZHOU Z, WU Q, YAN Z, et al. Extracellular RNA in a single droplet of human serum reflects physiologic and disease states[J]. Proc Natl Acad Sci U S A, 2019, 116(38): 19200-19208. DOI: 10.1073/pnas.1908252116.
    [31]
    BEST MG, SOL N, KOOI I, et al. RNA-seq of tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular pathway cancer diagnostics[J]. Cancer Cell, 2015, 28(5): 666-676. DOI: 10.1016/j.ccell.2015.09.018.
    [32]
    MUTHUKUMAR T, DADHANIA D, DING R, et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients[J]. N Engl J Med, 2005, 353(22): 2342-2351. DOI: 10.1056/NEJMoa051907.
    [33]
    AMIRZARGAR A, LESSANPEZESHKI M, FATHI A, et al. Th1/Th2 cytokine analysis in Iranian renal transplant recipients[J]. Transplant Proc, 2005, 37(7): 2985-2987. DOI: 10.1016/j.transproceed.2005.08.004.
    [34]
    JIA Y, WEI Y. Modulators of microRNA function in the immune system[J]. Int J Mol Sci, 2020, 21(7): 2357. DOI: 10.3390/ijms21072357.
    [35]
    HASSAN NE, MOSELHY WA, ELDOMANY EB, et al. Evaluation of miRNA-16-2-3P, miRNA-618 levels and their diagnostic and prognostic value in the regulation of immune response during SARS Cov-2 infection[J]. Immunogenetics, 2023, 75(4): 403-410. DOI: 10.1007/s00251-023-01308-6.
    [36]
    SAWITZKI B, SCHLICKEISER S, REINKE P, et al. Monitoring tolerance and rejection in organ transplant recipients[J]. Biomarkers, 2011, 16(Suppl 1): S42-S50. DOI: 10.3109/1354750X.2011.578754.
    [37]
    DÖCKE WD, HÖFLICH C, DAVIS KA, et al. Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study[J]. Clin Chem, 2005, 51(12): 2341-2347. DOI: 10.1373/clinchem.2005.052639.
    [38]
    VAN GELDER T, VAN SCHAIK RH, HESSELINK DA. Pharmacogenetics and immunosuppressive drugs in solid organ transplantation[J]. Nat Rev Nephrol, 2014, 10(12): 725-731. DOI: 10.1038/nrneph.2014.172.
    [39]
    SOOD S, TESTRO AG. Immune monitoring post liver transplant[J]. World J Transplant, 2014, 4(1): 30-39. DOI: 10.5500/wjt.v4.i1.30.
    [40]
    LIEW CC, DZAU VJ. Molecular genetics and genomics of heart failure[J]. Nat Rev Genet, 2004, 5(11): 811-825. DOI: 10.1038/nrg1470.
    [41]
    TSUANG MT, NOSSOVA N, YAGER T, et al. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report[J]. Am J Med Genet B Neuropsychiatr Genet, 2005, 133B(1): 1-5. DOI: 10.1002/ajmg.b.30161.
    [42]
    MARSHALL KW, ZHANG H, YAGER TD, et al. Blood-based biomarkers for detecting mild osteoarthritis in the human knee[J]. Osteoarthritis Cartilage, 2005, 13(10): 861-871. DOI: 10.1016/j.joca.2005.06.002.
    [43]
    MA J, LIEW CC. Gene profiling identifies secreted protein transcripts from peripheral blood cells in coronary artery disease[J]. J Mol Cell Cardiol, 2003, 35(8): 993-998. DOI: 10.1016/s0022-2828(03)00179-2.
    [44]
    VANBUREN P, MA J, CHAO S, et al. Blood gene expression signatures associate with heart failure outcomes[J]. Physiol Genomics, 2011, 43(8): 392-397. DOI: 10.1152/physiolgenomics.00175.2010.
    [45]
    BURAKOFF R, HANDE S, MA J, et al. Differential regulation of peripheral leukocyte genes in patients with active Crohn’s disease and Crohn’s disease in remission[J]. J Clin Gastroenterol, 2010, 44(2): 120-126. DOI: 10.1097/MCG.0b013e3181a9ef53.
    [46]
    MARSHALL KW, MOHR S, KHETTABI FE, et al. A blood-based biomarker panel for stratifying current risk for colorectal cancer[J]. Int J Cancer, 2010, 126(5): 1177-1186. DOI: 10.1002/ijc.24910.
    [47]
    CAO S, ZHANG Q, SONG L, et al. Dysregulation of innate and adaptive immune responses in asymptomatic SARS-CoV-2 infection with delayed viral clearance[J]. Int J Biol Sci, 2022, 18(12): 4648-4657. DOI: 10.7150/ijbs.72963.
    [48]
    LIU D, LIU B, LIN C, et al. Imbalance of peripheral lymphocyte subsets in patients with ankylosing spondylitis: a meta-analysis[J]. Front Immunol, 2021, 12: 696973. DOI: 10.3389/fimmu.2021.696973.
    [49]
    HE YT, ZHOU Y, SHAO Q, et al. Immunoregulatory effects of subcutaneous immunotherapy on lymphocyte subgroups and cytokines in children with asthma[J]. J Immunol Res, 2019: 7024905. DOI: 10.1155/2019/7024905.
    [50]
    寇建涛, 李先亮, 朱继巧, 等. 自创免疫状态量化评分标准评估肝移植受者术后免疫状态的可行性分析[J]. 中华器官移植杂志, 2020, 41(6): 362-366. DOI: 10.3760/cma.j.cn421203-20191110-00407.

    KOU JT, LI XL, ZHU JQ, et al. Application of Mingdao immune score system for evaluating the immune status of liver transplant recipients[J]. Chin J Organ Transplant, 2020, 41(6): 362-366. DOI: 10.3760/cma.j.cn421203-20191110-00407.
    [51]
    UEMURA T, RILEY TR, KHAN A, et al. Immune functional assay for immunosuppressive management in post-transplant malignancy[J]. Clin Transplant, 2011, 25(1): E32-E37. DOI: 10.1111/j.1399-0012.2010.01303.x.
    [52]
    LEVITSKY J. Next level of immunosuppression: drug/immune monitoring[J]. Liver Transpl, 2011, 17(Suppl 3): S60-S65. DOI: 10.1002/lt.22385.
    [53]
    NANKIVELL BJ, PʼNG CH, OʼCONNELL PJ, et al. Calcineurin inhibitor nephrotoxicity through the lens of longitudinal histology: comparison of cyclosporine and tacrolimus eras[J]. Transplantation, 2016, 100(8): 1723-1731. DOI: 10.1097/TP.0000000000001243.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (178) PDF downloads(107) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return